{"id":"acr16","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Without access to detailed clinical trial data or published mechanism information, the precise molecular target and pharmacological action of ACR16 cannot be reliably determined. Phase 3 status indicates it has progressed beyond early-stage testing, but the mechanism remains proprietary or undisclosed in available sources.","oneSentence":"ACR16 is an investigational therapeutic in phase 3 development by Teva, but its specific mechanism of action is not publicly disclosed.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:44:13.341Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT00724048","phase":"PHASE2","title":"A Study of Pridopidine (ACR16) for the Treatment of Participants With Huntington's Disease","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2008-10-24","conditions":"Huntington Disease","enrollment":227},{"nctId":"NCT00665223","phase":"PHASE3","title":"A Study of Treatment With Pridopidine (ACR16) in Participants With Huntington's Disease","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2008-04-24","conditions":"Huntington's Disease","enrollment":437},{"nctId":"NCT01306929","phase":"PHASE2","title":"Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease","status":"COMPLETED","sponsor":"Prilenia","startDate":"2011-03-24","conditions":"Huntington Disease","enrollment":134}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":63,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Pridopidine","pridopidine"],"phase":"phase_3","status":"active","brandName":"ACR16","genericName":"ACR16","companyName":"Teva Branded Pharmaceutical Products R&D, Inc.","companyId":"teva-branded-pharmaceutical-products-r-d-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":2},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}